Detalles de la búsqueda
1.
Systemic immune mediators reflect tumour-infiltrating lymphocyte intensity and predict therapeutic response in triple-negative breast cancer.
Immunology
; 169(2): 229-241, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36703241
2.
Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma.
Int J Mol Sci
; 23(23)2022 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36499015
3.
A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.
BMC Cancer
; 21(1): 901, 2021 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34362334
4.
The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115).
Breast Cancer Res Treat
; 183(3): 749-757, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32728860
5.
Gas chromatography-mass spectrometry untargeted profiling of non-Hodgkin's lymphoma urinary metabolite markers.
Anal Bioanal Chem
; 412(27): 7469-7480, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32897412
6.
Loss of prion protein is associated with the development of insulin resistance and obesity.
Biochem J
; 474(17): 2981-2991, 2017 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28739602
7.
Low PTEN expression is associated with worse overall survival in head and neck squamous cell carcinoma patients treated with chemotherapy and cetuximab.
Int J Clin Oncol
; 20(2): 282-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24858479
8.
Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC-RELANCE/LACOG 0118.
JTO Clin Res Rep
; 5(3): 100646, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38434771
9.
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
Target Oncol
; 18(3): 425-440, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37017806
10.
Patient-centered trials in oncology: Time for a change.
Med
; 3(7): 445-449, 2022 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35809559
11.
Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy.
Front Immunol
; 13: 984349, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36091058
12.
Assessing Oncologists' Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in Brazil.
JTO Clin Res Rep
; 3(10): 100402, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36193188
13.
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP).
Lung Cancer
; 170: 114-121, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35753125
14.
Immunotherapy as Single Treatment for Patients With NSCLC With Brain Metastases: A Systematic Review and Meta-Analysis-the META-L-BRAIN Study.
J Thorac Oncol
; 16(8): 1379-1391, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33964398
15.
Mutational Signatures Driven by Epigenetic Determinants Enable the Stratification of Patients with Gastric Cancer for Therapeutic Intervention.
Cancers (Basel)
; 13(3)2021 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33513945
16.
Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic.
Front Oncol
; 10: 1068, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32714871
17.
Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 21(6): e511-e515, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32389509
18.
Predictors of peritoneal carcinomatosis in patients with gastric cancer treated at a single institution in Brazil.
J Surg Oncol
; 100(6): 452-5, 2009 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19697363
19.
Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil.
Int J Clin Oncol
; 14(4): 326-31, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19705243
20.
NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients.
NPJ Breast Cancer
; 5: 11, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30963110